Athersys Is Poised To Snatch The Holy Grail Of Acute Injury
Seeking Alpha,
Summary Athersys may be first to fully tap the gigantic ischemic stroke market.
Summary Athersys may be first to fully tap the gigantic ischemic stroke market.
The cutting-edge treatment for stroke isn’t an elegantly crafted drug or a gene therapy, but a device that works like a pipe…
The cutting-edge treatment for stroke isn’t an elegantly crafted drug or a gene therapy, but a device that works like a pipe…